Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
Claudio G. Brunstein(Hotel Dieu Hospital), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Siddhartha Ganguly(University of Kansas Medical Center), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Oscar Lahoud(Memorial Sloan Kettering Cancer Center), Leona Holmberg, John Rogosheske(University of Minnesota), Seth J. Rotz(Cleveland Clinic), Mingwei Fei(Medical College of Wisconsin), Vaibhav Agrawal(City Of Hope National Medical Center), Gerhard Hildebrandt(University of Missouri Health System), Ibrahim Ahmed(Children's Mercy Hospital), Marcos de Lima(The Ohio State University), Harry C. Schouten, Vikram Mathews(Christian Medical College & Hospital), Peiman Hematti(UW Health University Hospital), Jan Černý(Worcester Memorial Hospital), Joseph Bubalo(Oregon Health & Science University), Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Shahrukh K. Hashmi(Mayo Clinic), Sachiko Seo(National Cancer Center Hospital East), Lynette Chee(The Royal Melbourne Hospital), Taiga Nishihori(Moffitt Cancer Center), Baldeep Wirk(Boston University), Nelli Bejanyan(Moffitt Cancer Center), Shin Mineishi(University of Alabama at Birmingham), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Richard F. Olsson(AstraZeneca (Netherlands)), Minoo Battiwalla(Sarah Cannon), Kehinde Adekola(Northwestern Memorial Hospital), Richard T. Maziarz(Oregon Health & Science University), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Ran Reshef(Abramson Cancer Center), Marcelo C. Pasquini(Cleveland Clinic), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Stefan O. Ciurea(University of California, Irvine), Jean A. Yared(University of Maryland, Baltimore), Soyoung Kim(Medical College of Wisconsin), Heather Landau(Memorial Sloan Kettering Cancer Center)
Cited by 13
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986